ConductScience.org, home

Paper21782

The pharmacologic disposition of 4'-(9-acridinylamino)methanesulfon-m-anisidide in mice and rats.

Cysyk RL and 2 others. Drug Metab Dispos, 1977. Cited by 75 papers, by iCite.

Cite this record

ConductScience Library. The pharmacologic disposition of 4'-(9-acridinylamino)methanesulfon-m-anisidide in mice and rats. Papers, record 21782. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21782

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The pharmacologic disposition of 4'-(9-acridinylamino)methanesulfon-m-anisidide in mice and rats.
PubMed
Journal
Drug Metab Dispos
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
75
iCite
Relative citation ratio, by iCite
3.92
iCite
Revised in PubMed
2013-11-21
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cysyk RLR L
2Shoemaker DD
3Adamson RHR H

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcridinesMajor topic
Antineoplastic AgentsMajor topic
Animals
Bile
Blood Proteins
Dose-Response Relationship, Drug
Glutathione
Glutathione Transferase
Liver
Male
Mice
Phenylenediamines
Protein Binding
Rats
Spleen
Tissue Distribution

Source PubMed

Download CSV of topics

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 75 citations.

PMIDTitleJournalYearIn PapersSource
7190020Interaction of human serum albumin with anticancer agents in vitro.Br J Cancer1980https://conductscience.org/library/papers/7190020PubMed
6961970Successful treatment of a patient with acute nonlymphoblastic leukemia (ANLL) and anthracycline cardiomyopathy with 4' (9-acridinylamino) methanesulfon-m-anisidide (AMSA).Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6961970PubMed
6893934Enhanced killing of mammalian cells by radiation combined with m-AMSA.Br J Cancer1980https://conductscience.org/library/papers/6893934PubMed
6583026Human tissue distribution of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (NSC 141549, AMSA).Cancer Chemother Pharmacol1984https://conductscience.org/library/papers/6583026PubMed
6273006A phase II clinical study of mAMSA in small cell carcinoma of the lung.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/6273006PubMed
3855288Pharmacokinetics of amsacrine in patients receiving combined chemotherapy for treatment of acute myelogenous leukemia.Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/3855288PubMed
3755785The tissue localization of m-AMSA and its effect on thymidine incorporation in various tissues in vivo.Med Oncol Tumor Pharmacother1986https://conductscience.org/library/papers/3755785PubMed
3754493
Comparison of the pharmacokinetics and protein binding of the anticancer drug, amsacrine and a new analogue, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino)phenyl-amino] -4-acridinecarboxamide in rabbits.
Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3754493PubMed
1914082Inhibition of 7-hydroxymethotrexate formation by amsacrine.Cancer Chemother Pharmacol1991https://conductscience.org/library/papers/1914082PubMed
393427m-AMSA and PALA: two new agents in cancer chemotherapy.Cancer Chemother Pharmacol1979https://conductscience.org/library/papers/393427PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21782

GET https://conductscience.org/api/papers/v1/21782/authors